The American College of Cardiology (ACC) announced the selection of Timothy W. Attebery, MBA, to serve as its chief executive officer, effective Sept. 1.
Boston Scientific announced its acquisition of Santa Rosa, California-based Claret Medical in a transaction that includes $220 million upfront and an additional potential reimbursement-based milestone payment of up to $50 million. The deal is expected to close before the end of the year.
Epinephrine doses administered by paramedics significantly improved the odds of 30-day survival for patients following out-of-hospital cardiac arrest (OHCA), according to a randomized, placebo-controlled trial published in the New England Journal of Medicine. The survivors who received epinephrine, however, had worse neurological outcomes.
July 19, 2018 | Hypertension
A hypertension management protocol from an integrated healthcare system was successfully adopted by a network of safety-net clinics, resulting in substantial improvements in blood pressure control for patients of all races.
“Tele-stenting” appears more possible now than ever, as Vascular Robotics announced an interventional cardiologist used its CorPath GRX System to perform a remote percutaneous coronary intervention (PCI) in a pig 100 miles away.
As CMS revisits the procedural volume requirements for centers to start and maintain a transcatheter aortic valve replacement (TAVR) program, several professional societies argued for direct TAVR experience to factor more strongly into the new standards.
Individuals with the human immunodeficiency virus (HIV) are twice as likely to develop cardiovascular disease, according to a global analysis published on July 18 in the American Heart Association’s journal Circulation.
Pediatric ventricular assist devices (VADs) have been associated with better survival to heart transplantation in recent years, but infants and those with congenital heart disease (CHD) continue to have worse outcomes, researchers reported in the Journal of the American College of Cardiology.
July 18, 2018 | Heart Failure
Despite decreases in heart failure (HF) incidence and mortality rates in ambulatory patients, mortality remains higher for women, according to a new study published July 16 in the Canadian Medical Association Journal.
July 18, 2018 | Acute Coronary Syndrome
Marijuana use before an acute myocardial infarction (AMI) lowers the odds of in-hospital mortality by 21 percent, according to multicenter analysis of more than 1.2 million patients published in PLOS One.
July 18, 2018 | Acute Coronary Syndrome
Regular physical activity, even in areas with moderate to high levels of traffic pollution, is still effective in reducing the risk of first and recurrent myocardial infarction (MI), according to a study published online July 18 in the Journal of the American Heart Association.
Valve-in-valve TAVR (ViV-TAVR) of a failed surgical valve was associated with comparable—and perhaps even better—clinical outcomes when compared to TAVR performed in native valves, according to a registry study published in the Journal of the American College of Cardiology.
July 17, 2018 | Heart Failure
Stem cells can be used to “encourage” better function in heart failure (HF) patients in the U.K., according to a recent stem cell therapy trial spearheaded by researchers from the University of Edinburgh. Harvested from bone marrow, the stem cells, which were able to generate new cardiac tissue and blood vessels, had a success rate of 80 percent.
July 17, 2018 | Acute Coronary Syndrome
Cardiovascular disease (CVD) caused more than a quarter of all deaths in India in 2015, according to a new study in The Lancet Global Health, with rural residents and young adults accounting for most of the recent uptick.
July 17, 2018 | Vascular & Endovascular
Contrary to popular belief, full-fat dairy products are not directly associated with increasing cardiovascular disease (CVD) and stroke mortality, according to a new study published in the American Journal of Clinical Nutrition.
July 17, 2018 | Heart Failure
Despite guidelines and quality improvement efforts, many people with heart failure with reduced ejection fraction (HFrEF) aren’t prescribed the recommended medications. And among those who are, fewer than one-fourth receive optimal doses, according to a registry analysis of ambulatory patients.
Asthma and uncontrolled asthma are associated with a 38 percent increased risk of developing atrial fibrillation (AFib), according to new research published in JAMA Cardiology.
July 17, 2018 | Vascular & Endovascular
A Cleveland-based startup called XaTek has developed a handheld device that can inform users or physicians about their blood’s clotting ability within 30 minutes.
July 16, 2018 | Vascular & Endovascular
Low doses (75-100 mg per day) of aspirin were found to be ineffective for people above 154 pounds, while higher doses only reduced cardiovascular events among patients with greater body size.
July 16, 2018 | Vascular & Endovascular
A retrospective study published July 13 in JAMA Network Open suggests placement of an inferior vena cava (IVC) filter is associated with an increased risk of 30-day mortality for patients with venous thromboembolic disease and a contraindication to anticoagulants.
With its potential to tap into a myriad of hospital services and departments, hypertrophic cardiomyopathy is drawing interest from medical centers committed to improving the lives of their patients and bolstering the bottom line.
Mergers are a lot like arranged marriages in that there’s little or no opportunity for the parties to build relationships before their union is finalized. Building a united team requires much more than a mandate from leadership.
July 16, 2018 | Acute Coronary Syndrome
A new study published in the Journal of the American Heart Association suggests greater adherence to a Southern (U.S.) diet is associated with a 56 percent increased risk of coronary heart disease (CHD) when compared to those with a Mediterranean diet.